Neurilemmoma clinical trials
The registry lists 27 studies for Neurilemmoma across 7 countries. 11 are recruiting or about to start. 7 of them are mainly about Neurilemmoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28. Counting its 2 narrower conditions too, such as Neuroma, Acoustic: 143 studies, 41 open.
Get an email when these change. Save the Neurilemmoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Strasbourg, France (4) · Seoul National University Hospital (2) · Massachusetts General Hospital (2) · Jona Hattangadi-Gluth (1) · Peking Union Medical College Hospital (1) · Huazhong University of Science and Technology (1) · Imperial College London (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
What is being tested here
Drugs under test in Neurilemmoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027Screening Trial for Pain Relief in Schwannomatosis (STARFISH) · Massachusetts General Hospital
Who these studies take
Of the 11 Neurilemmoma studies recruiting now, 8 (73%) set no upper age limit and 1 (9%) stop at 75 or younger. 2 (18%) take children under 18. 1 (9%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (18%) | 2 (18%) |
| 18 | 11 (100%) | 10 (91%) |
| 30 | 11 (100%) | 10 (91%) |
| 40 | 11 (100%) | 10 (91%) |
| 50 | 11 (100%) | 10 (91%) |
| 65 | 11 (100%) | 10 (91%) |
| 75 | 11 (100%) | 10 (91%) |
| 85 | 10 (91%) | 9 (82%) |
Across all 27 studies, recruiting or not: 7% stop at 75 or younger and 0% at 65; 15% take children; 4% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Natural History Study of Patients With Neurofibromatosis Type 2RecruitingNCT005983511 country
- Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT046484621 country
- Screening Trial for Pain Relief in Schwannomatosis (STARFISH)RecruitingNCT05684692Phase 21 country
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsRecruitingNCT055761031 country
- Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI StudyRecruitingNCT04278118Not applicable1 country
- Evaluation of the CONVIVO SystemRecruitingNCT05139277Not applicable1 country
- Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor DiagnosisRecruitingNCT070781361 country
- SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)RecruitingNCT052541971 country
- Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgeryRecruitingNCT06112509Not applicable1 country
- Establishing Prospective Mediastinal Tumor Database of PUMCHRecruitingNCT064218051 country
- How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal SchwannomaRecruitingNCT063134111 country
- Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaTerminatedNCT02282917Early Phase 11 country
- CyberKnife Radiotherapy for the Treatment of SchwannomasCompletedNCT078015601 country
- Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaSuspendedNCT01083966Phase 11 country
- Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentCompletedNCT06322342Phase 21 country
- Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to SchwannomatosisActive, not recruitingNCT04163419Phase 21 country
- Use of Non-invasive Optical Analysis in NeurosurgeryStatus unknownNCT04712214Not applicable1 country
- Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PETCompletedNCT03542773Phase 11 country
- Stereotactic Body Radiotherapy for Spine TumorsCompletedNCT01347307Not applicable1 country
- Evolution of Cochleovestibular SchwannomasStatus unknownNCT044178681 country
- Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRIStatus unknownNCT035935771 country
- MRI Scan and Intra-labyrinthine SchwannomaStatus unknownNCT035808501 country
- Antineoplaston Therapy in Treating Patients With Neurofibroma and SchwannomaTerminatedNCT02988726Phase 21 country
- Hippocampal Radiation Exposure and MemoryCompletedNCT006036941 country
- Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT00973739Phase 21 country
- Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary SchwannomaCompletedNCT019513651 country
- Analysis of NF2 Mutations in Radiation-Related Neural TumorsCompletedNCT003404961 country